Jinal Bhiman to South Africa
This is a "connection" page, showing publications Jinal Bhiman has written about South Africa.
Connection Strength
0,411
-
Characteristics of infections with ancestral, Beta and Delta variants of SARS-CoV-2 in the PHIRST-C community cohort study, South Africa, 2020-2021. BMC Infect Dis. 2024 Mar 21; 24(1):336.
Score: 0,023
-
Healthcare utilization during the first two waves of the COVID-19 epidemic in South Africa: A cross-sectional household survey. PLoS One. 2023; 18(8):e0290787.
Score: 0,022
-
Knowledge, attitudes, practices and intention to get vaccinated against COVID-19: results from a cross-sectional survey in three peri-urban communities in South Africa. Pan Afr Med J. 2023; 45:120.
Score: 0,022
-
Efficacy of primary series AZD1222 (ChAdOx1 nCoV-19) vaccination against SARS-CoV-2 variants of concern: Final analysis of a randomized, placebo-controlled, phase 1b/2 study in South African adults (COV005). Vaccine. 2023 05 26; 41(23):3486-3492.
Score: 0,022
-
Household Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 From Adult Index Cases With and Without Human Immunodeficiency Virus in South Africa, 2020-2021: A Case-Ascertained, Prospective, Observational Household Transmission Study. Clin Infect Dis. 2023 02 08; 76(3):e71-e81.
Score: 0,022
-
Rapidly shifting immunologic landscape and severity of SARS-CoV-2 in the Omicron era in South Africa. Nat Commun. 2023 01 16; 14(1):246.
Score: 0,021
-
High prevalence of SARS-CoV-2 antibodies in pregnant women after the second wave of infections in the inner-city of Johannesburg, Gauteng Province, South Africa. Int J Infect Dis. 2022 Dec; 125:241-249.
Score: 0,021
-
Clinical severity of SARS-CoV-2 Omicron BA.4 and BA.5 lineages compared to BA.1 and Delta in South Africa. Nat Commun. 2022 10 04; 13(1):5860.
Score: 0,021
-
Emergence of SARS-CoV-2 Omicron lineages BA.4 and BA.5 in South Africa. Nat Med. 2022 09; 28(9):1785-1790.
Score: 0,021
-
SARS-CoV-2 Seroprevalence after Third Wave of Infections, South Africa. Emerg Infect Dis. 2022 May; 28(5):1055-1058.
Score: 0,020
-
SARS-CoV-2 incidence, transmission, and reinfection in a rural and an urban setting: results of the PHIRST-C cohort study, South Africa, 2020-21. Lancet Infect Dis. 2022 Jun; 22(6):821-834.
Score: 0,020
-
Convalescent plasma in the treatment of moderate to severe COVID-19 pneumonia: a randomized controlled trial (PROTECT-Patient Trial). Sci Rep. 2022 02 15; 12(1):2552.
Score: 0,020
-
Early assessment of the clinical severity of the SARS-CoV-2 omicron variant in South Africa: a data linkage study. Lancet. 2022 01 29; 399(10323):437-446.
Score: 0,020
-
Rapid epidemic expansion of the SARS-CoV-2 Omicron variant in southern Africa. Nature. 2022 03; 603(7902):679-686.
Score: 0,020
-
SARS-CoV-2 Seroprevalence in a Rural and Urban Household Cohort during First and Second Waves of Infections, South Africa, July 2020-March 2021. Emerg Infect Dis. 2021 12; 27(12):3020-3029.
Score: 0,020
-
Difference in mortality among individuals admitted to hospital with COVID-19 during the first and second waves in South Africa: a cohort study. Lancet Glob Health. 2021 09; 9(9):e1216-e1225.
Score: 0,019
-
Decline of influenza and respiratory syncytial virus detection in facility-based surveillance during the COVID-19 pandemic, South Africa, January to October 2020. Euro Surveill. 2021 07; 26(29).
Score: 0,019
-
Efficacy of the ChAdOx1 nCoV-19 Covid-19 Vaccine against the B.1.351 Variant. N Engl J Med. 2021 05 20; 384(20):1885-1898.
Score: 0,019
-
Detection of a SARS-CoV-2 variant of concern in South Africa. Nature. 2021 04; 592(7854):438-443.
Score: 0,019
-
Sixteen novel lineages of SARS-CoV-2 in South Africa. Nat Med. 2021 03; 27(3):440-446.
Score: 0,019